• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜图像分析中的人工智能:发展、进展与挑战

Artificial intelligence in retinal image analysis: Development, advances, and challenges.

作者信息

Oganov Anthony C, Seddon Ian, Jabbehdari Sayena, Uner Ogul E, Fonoudi Hossein, Yazdanpanah Ghasem, Outani Oumaima, Arevalo J Fernando

机构信息

Department of Ophthalmology, Renaissance School of Medicine, Stony Brook, NY, USA.

College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.

出版信息

Surv Ophthalmol. 2023 Sep-Oct;68(5):905-919. doi: 10.1016/j.survophthal.2023.04.001. Epub 2023 Apr 26.

DOI:10.1016/j.survophthal.2023.04.001
PMID:37116544
Abstract

Modern advances in diagnostic technologies offer the potential for unprecedented insight into ophthalmic conditions relating to the retina. We discuss the current landscape of artificial intelligence in retina with respect to screening, diagnosis, and monitoring of retinal pathologies such as diabetic retinopathy, diabetic macular edema, central serous chorioretinopathy, and age-related macular degeneration. We review the methods used in these models and evaluate their performance in both research and clinical contexts and discuss potential future directions for investigation, use of multiple imaging modalities in artificial intelligence algorithms, and challenges in the application of artificial intelligence in retinal pathologies.

摘要

诊断技术的现代进展为以前所未有的方式洞察与视网膜相关的眼科疾病提供了可能性。我们讨论了视网膜人工智能在糖尿病视网膜病变、糖尿病性黄斑水肿、中心性浆液性脉络膜视网膜病变和年龄相关性黄斑变性等视网膜疾病的筛查、诊断和监测方面的现状。我们回顾了这些模型中使用的方法,评估了它们在研究和临床环境中的性能,并讨论了未来潜在的研究方向、人工智能算法中多种成像模态的使用以及人工智能在视网膜疾病应用中的挑战。

相似文献

1
Artificial intelligence in retinal image analysis: Development, advances, and challenges.视网膜图像分析中的人工智能:发展、进展与挑战
Surv Ophthalmol. 2023 Sep-Oct;68(5):905-919. doi: 10.1016/j.survophthal.2023.04.001. Epub 2023 Apr 26.
2
Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers.糖尿病视网膜病变和黄斑水肿的多模态影像学:生物标志物的最新进展。
Surv Ophthalmol. 2024 Nov-Dec;69(6):893-904. doi: 10.1016/j.survophthal.2024.06.006. Epub 2024 Jun 26.
3
Application of different imaging modalities for diagnosis of Diabetic Macular Edema: A review.不同成像方式在糖尿病性黄斑水肿诊断中的应用:综述
Comput Biol Med. 2015 Nov 1;66:295-315. doi: 10.1016/j.compbiomed.2015.09.012. Epub 2015 Sep 25.
4
Topography of diabetic macular oedema compared with fluorescein angiography.糖尿病性黄斑水肿的地形图与荧光素血管造影的比较。
Acta Ophthalmol Scand. 2007 Feb;85(1):32-9. doi: 10.1111/j.1600-0420.2006.00727.x.
5
Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema.糖尿病性黄斑水肿的频域光学相干断层扫描结果与荧光素血管造影模式之间的相关性
Ophthalmology. 2009 Jun;116(6):1158-67. doi: 10.1016/j.ophtha.2008.12.063. Epub 2009 Apr 23.
6
New imaging systems in diabetic retinopathy.糖尿病视网膜病变的新型成像系统。
Acta Diabetol. 2019 Sep;56(9):981-994. doi: 10.1007/s00592-019-01373-y. Epub 2019 Jun 15.
7
Diabetic retinopathy and ultrawide field imaging.糖尿病视网膜病变与超广角成像。
Semin Ophthalmol. 2020 Jan 2;35(1):56-65. doi: 10.1080/08820538.2020.1729818. Epub 2020 Mar 13.
8
Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy.糖尿病性黄斑水肿和糖尿病性视网膜病变的影像学和生物标志物。
Curr Diab Rep. 2019 Aug 31;19(10):95. doi: 10.1007/s11892-019-1226-2.
9
Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema.病理性神经血管单元在糖尿病性黄斑水肿的多模态成像中的定位。
Medicina (Kaunas). 2023 May 7;59(5):896. doi: 10.3390/medicina59050896.
10
Artificial intelligence in screening, diagnosis, and classification of diabetic macular edema: A systematic review.人工智能在糖尿病性黄斑水肿的筛查、诊断和分类中的应用:系统评价。
Surv Ophthalmol. 2023 Jan-Feb;68(1):42-53. doi: 10.1016/j.survophthal.2022.08.004. Epub 2022 Aug 12.

引用本文的文献

1
Research Progress in Artificial Intelligence for Central Serous Chorioretinopathy: A Systematic Review.人工智能在中心性浆液性脉络膜视网膜病变中的研究进展:一项系统综述
Ophthalmol Ther. 2025 Jul 22. doi: 10.1007/s40123-025-01209-9.
2
Deep learning-driven approach for cataract management: towards precise identification and predictive analytics.深度学习驱动的白内障管理方法:迈向精确识别和预测分析
Front Cell Dev Biol. 2025 May 30;13:1611216. doi: 10.3389/fcell.2025.1611216. eCollection 2025.
3
AI-assisted ophthalmic imaging for early detection of neurodegenerative diseases.
用于神经退行性疾病早期检测的人工智能辅助眼科成像。
Int J Emerg Med. 2025 May 6;18(1):90. doi: 10.1186/s12245-025-00870-y.
4
Hybrid model of feature-driven modular neural network-based grasshopper optimization algorithm for diabetic retinopathy classification using fundus images.基于特征驱动模块化神经网络的蚱蜢优化算法的混合模型用于使用眼底图像进行糖尿病视网膜病变分类
Med Biol Eng Comput. 2025 Mar 6. doi: 10.1007/s11517-025-03307-z.
5
Integrating Retinal Segmentation Metrics with Machine Learning for Predictions from Mouse SD-OCT Scans.将视网膜分割指标与机器学习相结合,用于从小鼠谱域光学相干断层扫描(SD-OCT)图像进行预测。
Curr Eye Res. 2025 May;50(5):502-511. doi: 10.1080/02713683.2025.2456783. Epub 2025 Jan 23.
6
Faricimab efficacy in type 1 macular neovascularization: AI-assisted quantification of pigment epithelium detachment (PED) volume reduction over 12 months in Naïve and switch eyes.法西单抗治疗1型黄斑新生血管的疗效:初治眼和转换眼12个月内色素上皮脱离(PED)体积减少的人工智能辅助定量分析
Int J Retina Vitreous. 2025 Jan 9;11(1):3. doi: 10.1186/s40942-025-00629-w.
7
Molecular-Genetic Biomarkers of Diabetic Macular Edema.糖尿病性黄斑水肿的分子遗传生物标志物
J Clin Med. 2024 Dec 5;13(23):7426. doi: 10.3390/jcm13237426.
8
Intraretinal hyperreflective line: potential biomarker in various retinal disorders.视网膜内高反射线:多种视网膜疾病中的潜在生物标志物。
Med Hypothesis Discov Innov Ophthalmol. 2024 Oct 14;13(3):129-138. doi: 10.51329/mehdiophthal1504. eCollection 2024 Fall.
9
Application of artificial intelligence in glaucoma care: An updated review.人工智能在青光眼护理中的应用:最新综述。
Taiwan J Ophthalmol. 2024 Sep 13;14(3):340-351. doi: 10.4103/tjo.TJO-D-24-00044. eCollection 2024 Jul-Sep.
10
Importance of OCT-derived biomarkers for the recurrence of central serous chorioretinopathy using statistics and predictive modelling.利用统计学和预测模型评估 OCT 衍生生物标志物在中心性浆液性脉络膜视网膜病变复发中的重要性。
Sci Rep. 2024 Oct 13;14(1):23940. doi: 10.1038/s41598-024-75275-7.